Notre groupe organise plus de 3 000 séries de conférences Événements chaque année aux États-Unis, en Europe et en Europe. Asie avec le soutien de 1 000 autres Sociétés scientifiques et publie plus de 700 Open Access Revues qui contiennent plus de 50 000 personnalités éminentes, des scientifiques réputés en tant que membres du comité de rédaction.
Les revues en libre accès gagnent plus de lecteurs et de citations
700 revues et 15 000 000 de lecteurs Chaque revue attire plus de 25 000 lecteurs
Gary R Skankey and Christopher Breeden
We report a patient, PCR positive for COVID 19, who developed respiratory failure and cytokine release syndrome, recovered after a prolonged period of mechanical ventilation, no longer require supplemental oxygen, and tested negative twice by COVID 19 PCR, relapsed within 40 days of initial infection. Laboratory findings, PO2 and chest radiograph findings were identical to the first episode, and COVID 19 PCR was again positive. Response was significantly better on remdesivir, now available, and the patient recovered with radiographic and respiratory recovery. Serum Covid 19 IgG drawn at the onset of the second episode was positive. This raised a few questions. First, was this a true relapse of infection? Second, if it was, does the IgG detected by the serum study, represent neutralizing antibody and be an indicator of immunity? Third, are there those who develop a weak, or incomplete immune response to the disease?